Orchid Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Orchid Pharma has informed the exchanges that its trading window will remain closed from July 1, 2025 until 48 hours after the declaration of its Q1 FY2025-26 financial results (standalone and consolidated). The Q1 period ends on June 30, 2025. This is a routine compliance action taken under SEBI's Insider Trading Regulations, 2015. All insiders and anyone in possession of unpublished price-sensitive information are prohibited from trading in the company's securities during this window. The board meeting date to consider and approve the Q1 results will be announced separately.
This is a routine regulatory compliance filing and does not directly impact shareholders or stock price. Investors should note that Q1 FY2025-26 results will be announced in due course, which could be a key catalyst.